| 106 | msn2;msn4_30_29_30_57_623 | wild-type_30_26_26_42_600 | - | — | 11.8320610687 | 15.3846153846 | 35.7142857143 | 1.76e-08 | 30°C | — | — |
| 276 | spe-9(hc88)_mir-71(OE)_20_15_23 | spe-9(hc88)_control_20_13_17 | - | mir-71 mutation | 15.3846153846 | — | 35.2941176471 | — | 20°C | — | — |
| 142 | S288c_VPH2(OE)_32_32_67_52 | S288c_WT_26_26_50_53 | - | VPH2 overexpression | 23.0769230769 | 25.0 | 34.0 | 0.0054 | — | — | — |
| 226 | w1118_PO163-GAL4/UAS-dTsc2_36_45_126 | w1118_+/PO163-GAL4_28_34_87 | - | gig overexpression | 28.5714285714 | — | 32.3529411765 | <0.0001 | — | — | — |
| 220 | w1118_24B-GAL4/UAS-dTsc2_37_45_107 | w1118_+/24B-GAL4_31_34_67 | - | gig overexpression | 19.3548387097 | — | 32.3529411765 | <0.0001 | — | — | — |
| 124 | afg3;hac1_30_30_32_50_40 | wild-type_30_23_24_38_40 | - | — | 32.3275862069 | 33.3333333333 | 31.5789473684 | 0.0349 | 30°C | — | — |
| 99 | afg3;gcn4_30_18_17_50_119 | wild-type_30_21_20_38_98 | - | — | -15.0943396226 | -15.0 | 31.5789473684 | 0.000482 | 30°C | — | — |
| 230 | w1118_DJ634-GAL4/UAS-dS6kKQ_31_40_110 | w1118_+/DJ634-GAL4_25_31_120 | - | Dominant-negative S6k | 24.0 | — | 29.0322580645 | <0.0001 | — | — | — |
| 206 | w1118_da-GAL4/UAS-dS6kKQ_30_40_122 | w1118_+/da-GAL4_26_31_92 | - | Dominant-negative S6k | 15.3846153846 | — | 29.0322580645 | <0.0001 | — | — | — |
| 224 | w1118_DJ634-GAL4/UAS-dTsc2_30_40_120 | w1118_+/DJ634-GAL4_24_31_120 | - | gig overexpression | 24.3902439024 | — | 29.0322580645 | <0.0001 | — | — | — |
| 200 | w1118_da-GAL4/UAS-dTsc1_29_40_136 | w1118_+/da-GAL4_26_31_29 | - | Tsc1 overexpression | 11.5384615385 | — | 29.0322580645 | <0.0001 | — | — | — |
| 204 | w1118_da-GAL4/UAS-dTORFRB_30_40_126 | w1118_+/da-GAL4_26_31_92 | - | Dominant negative Tor | 15.3846153846 | — | 29.0322580645 | <0.0001 | — | — | — |
| 238 | Oregon_minocycline_15_41 | Oregon_control_7_32 | - | Minocycline treatment | 114.285714286 | — | 28.125 | <0.0002 | — | male | — |
| 141 | S288c_VMA1(OE)_40_40_64_38 | S288c_WT_29_29_50_38 | DR | VMA1 overexpression | 37.9310344828 | 37.9310344828 | 28.0 | 0.076 | — | — | — |
| 348 | T23_1003_28 | T-GFP_803_14 | - | Bub1b overexpression | — | — | 24.9066002491 | — | — | — | — |
| 344 | T23_1246_29 | WT_999_30 | - | Bub1b overexpression | — | — | 24.7247247247 | — | — | — | — |
| 111 | atp5_30_27_27_53_55 | wild-type_30_25_23_43_35 | - | — | 8.33333333333 | 17.3913043478 | 23.2558139535 | 0.422 | 30°C | — | — |
| 119 | afg3_15_23_21_49_79 | wild-type_15_22_21_40_40 | - | AFG3 deletion | 5.38116591928 | — | 22.5 | 0.721 | 15°C | — | — |
| 70 | N2_Bristol_R02D3.3 | N2_Bristol_N2_Bristol | RNAi | R02D3.3 RNAi | 13.0 | — | 21.7 | — | — | — | — |
| 58 | N2_Bristol_F09F7.3 | N2_Bristol_N2_Bristol | RNAi | F09F7.3 RNAi | 8.1 | — | 21.7 | — | — | — | — |
| 57 | N2_Bristol_F54E7.2 | N2_Bristol_N2_Bristol | RNAi | rps-12 RNAi | 11.6 | — | 21.7 | — | — | — | — |
| 56 | N2_Bristol_C03C10.3 | N2_Bristol_N2_Bristol | RNAi | rnr-2 RNAi | 14.2 | — | 21.7 | — | — | — | — |
| 54 | N2_Bristol_F37C12.9 | N2_Bristol_N2_Bristol | RNAi | rps-14 RNAi | 16.6 | — | 21.7 | — | — | — | — |
| 76 | N2_Bristol_F18A1.5 | N2_Bristol_N2_Bristol | RNAi | rpa-1 RNAi | 5.1 | — | 21.7 | — | — | — | — |
| 129 | S288c_AVT1(OE)_37_37_62_32 | S288c_WT_28_29_51_32 | - | AVT1 overexpression | 27.8065630397 | 27.5862068966 | 21.568627451 | 0.00376 | — | — | — |
